Planning a Clinical Development Programme for Radiopharmaceuticals: An Analysis of International Guidelines and Expertise
INTRODUCTION. Current scientific knowledge in the field of molecular biology and the associated manufacturing and technical capabilities enable the development of radiopharmaceuticals (RPs) with high specificity to the target organs, tissues, and receptors. The development of novel RPs requires mand...
Saved in:
Main Authors: | D. V. Goryachev, I. V. Lysikova, A. A. Chernaia, D. D. Kushnir |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
2025-02-01
|
Series: | Регуляторные исследования и экспертиза лекарственных средств |
Subjects: | |
Online Access: | https://www.vedomostincesmp.ru/jour/article/view/721 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Radiopharmaceuticals: progress and clinical perspectives /
Published: (1986) -
Regulation of Radiopharmaceutical Products
by: V. V. Kosenko, et al.
Published: (2022-12-01) -
Potential of Theranostics in Visualisation of the Tumour Microenvironment and Elimination of Its Immunosuppressive Components
by: O. E. Molchanov, et al.
Published: (2022-12-01) -
Non-clinical Studies of Radiopharmaceuticals: Analysis of National and International Regulatory Practice (Review)
by: O. E. Klementyeva, et al.
Published: (2024-07-01) -
Development of a methodology for the analysis of radionuclide impurities in radiopharmaceuticals by gamma-ray spectrometry
by: Eduardo Bonfim De Paula, et al.
Published: (2017-11-01)